(MedPage Today) — Kinetic measures of a cerebrospinal fluid (CSF) biomarker test predicted cognitive decline in Parkinson’s disease and distinguished it from progressive supranuclear palsy (PSP), an analysis of data from three cohorts showed…
Source link : https://www.medpagetoday.com/neurology/parkinsonsdisease/116207
Author :
Publish date : 2025-06-23 20:15:00
Copyright for syndicated content belongs to the linked Source.
